Cargando…

Utility of VSRAD for diagnosing Alzheimer’s disease in patients screened for dementia

OBJECTIVE: To investigate the utility of the voxel-based specific regional analysis system for Alzheimer’s disease (VSRAD). METHODS: Clinical data from patients who underwent screening for dementia using VSRAD and the Japanese version of COGNISTAT, the Neurobehavioral Cognitive Status Examination, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Oshikubo, Gaku, Akahane, Akihisa, Unno, Aki, Watanabe, Yukako, Ikebuchi, Emi, Tochigi, Mamoru, Hayashi, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169355/
https://www.ncbi.nlm.nih.gov/pubmed/32299274
http://dx.doi.org/10.1177/0300060520917270
_version_ 1783523772443131904
author Oshikubo, Gaku
Akahane, Akihisa
Unno, Aki
Watanabe, Yukako
Ikebuchi, Emi
Tochigi, Mamoru
Hayashi, Naoki
author_facet Oshikubo, Gaku
Akahane, Akihisa
Unno, Aki
Watanabe, Yukako
Ikebuchi, Emi
Tochigi, Mamoru
Hayashi, Naoki
author_sort Oshikubo, Gaku
collection PubMed
description OBJECTIVE: To investigate the utility of the voxel-based specific regional analysis system for Alzheimer’s disease (VSRAD). METHODS: Clinical data from patients who underwent screening for dementia using VSRAD and the Japanese version of COGNISTAT, the Neurobehavioral Cognitive Status Examination, were retrospectively investigated to specify the domains of cognitive function that correlate with the statistical mean value of positive Z-scores in the target volume-of-interest (VOI). A receiver operating characteristic (ROC) curve was constructed to assess the mean value of positive Z-scores in discriminating patients with AD. RESULTS: A total of 72 patients were included (18 male and 54 female; 15 patients with AD). The mean value of positive Z-scores in the target VOI was significantly correlated with standardized COGNISTAT scores for Orientation and Memory in all patients (r = –0.35 and –0.38, respectively). ROC curve analysis revealed that a cut-off of 1.57 for mean value of positive Z-scores in the target VOI provided 69.4% accuracy in discriminating patients with AD, with a sensitivity of 0.80 and specificity of 0.67. CONCLUSIONS: The results evinced the value of VSRAD in diagnosing AD. The degree of atrophy represented by the target VOI may reflect impairments in Orientation and Memory, which are early stage symptoms observed in AD.
format Online
Article
Text
id pubmed-7169355
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-71693552020-04-27 Utility of VSRAD for diagnosing Alzheimer’s disease in patients screened for dementia Oshikubo, Gaku Akahane, Akihisa Unno, Aki Watanabe, Yukako Ikebuchi, Emi Tochigi, Mamoru Hayashi, Naoki J Int Med Res Retrospective Clinical Research Report OBJECTIVE: To investigate the utility of the voxel-based specific regional analysis system for Alzheimer’s disease (VSRAD). METHODS: Clinical data from patients who underwent screening for dementia using VSRAD and the Japanese version of COGNISTAT, the Neurobehavioral Cognitive Status Examination, were retrospectively investigated to specify the domains of cognitive function that correlate with the statistical mean value of positive Z-scores in the target volume-of-interest (VOI). A receiver operating characteristic (ROC) curve was constructed to assess the mean value of positive Z-scores in discriminating patients with AD. RESULTS: A total of 72 patients were included (18 male and 54 female; 15 patients with AD). The mean value of positive Z-scores in the target VOI was significantly correlated with standardized COGNISTAT scores for Orientation and Memory in all patients (r = –0.35 and –0.38, respectively). ROC curve analysis revealed that a cut-off of 1.57 for mean value of positive Z-scores in the target VOI provided 69.4% accuracy in discriminating patients with AD, with a sensitivity of 0.80 and specificity of 0.67. CONCLUSIONS: The results evinced the value of VSRAD in diagnosing AD. The degree of atrophy represented by the target VOI may reflect impairments in Orientation and Memory, which are early stage symptoms observed in AD. SAGE Publications 2020-04-17 /pmc/articles/PMC7169355/ /pubmed/32299274 http://dx.doi.org/10.1177/0300060520917270 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Retrospective Clinical Research Report
Oshikubo, Gaku
Akahane, Akihisa
Unno, Aki
Watanabe, Yukako
Ikebuchi, Emi
Tochigi, Mamoru
Hayashi, Naoki
Utility of VSRAD for diagnosing Alzheimer’s disease in patients screened for dementia
title Utility of VSRAD for diagnosing Alzheimer’s disease in patients screened for dementia
title_full Utility of VSRAD for diagnosing Alzheimer’s disease in patients screened for dementia
title_fullStr Utility of VSRAD for diagnosing Alzheimer’s disease in patients screened for dementia
title_full_unstemmed Utility of VSRAD for diagnosing Alzheimer’s disease in patients screened for dementia
title_short Utility of VSRAD for diagnosing Alzheimer’s disease in patients screened for dementia
title_sort utility of vsrad for diagnosing alzheimer’s disease in patients screened for dementia
topic Retrospective Clinical Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169355/
https://www.ncbi.nlm.nih.gov/pubmed/32299274
http://dx.doi.org/10.1177/0300060520917270
work_keys_str_mv AT oshikubogaku utilityofvsradfordiagnosingalzheimersdiseaseinpatientsscreenedfordementia
AT akahaneakihisa utilityofvsradfordiagnosingalzheimersdiseaseinpatientsscreenedfordementia
AT unnoaki utilityofvsradfordiagnosingalzheimersdiseaseinpatientsscreenedfordementia
AT watanabeyukako utilityofvsradfordiagnosingalzheimersdiseaseinpatientsscreenedfordementia
AT ikebuchiemi utilityofvsradfordiagnosingalzheimersdiseaseinpatientsscreenedfordementia
AT tochigimamoru utilityofvsradfordiagnosingalzheimersdiseaseinpatientsscreenedfordementia
AT hayashinaoki utilityofvsradfordiagnosingalzheimersdiseaseinpatientsscreenedfordementia